Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians

Br J Clin Pharmacol. 1985 Apr;19(4):483-7. doi: 10.1111/j.1365-2125.1985.tb02673.x.

Abstract

The genetically controlled mephenytoin p(4')-hydroxylation capacity was determined in 118 Caucasians and 70 Orientals. After an oral dose of 50 or 100 mg of racemic mephenytoin, the amount of p(4')-hydroxymephenytoin in 24 h urine was measured by gas chromatography. Bimodal distribution was found with 9/70 (13%) Orientals and 5/118 (4%) Caucasians demonstrating deficient p(4')-hydroxylation. The statistically significant difference between Orientals and Caucasians (P less than 0.05) was accounted for by the high incidence of poor metabolizers among the Japanese subjects, 7/31 (23%). The frequency among Chinese subjects, 2/39 (5%), was similar to the frequency among Caucasians.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Asian People*
  • Canada
  • China / ethnology
  • Chromatography, Gas
  • Female
  • Humans
  • Hydantoins / metabolism*
  • Hydroxylation
  • Japan / ethnology
  • Male
  • Mephenytoin / metabolism*
  • Mephenytoin / urine
  • Middle Aged
  • Polymorphism, Genetic*
  • White People

Substances

  • Hydantoins
  • Mephenytoin